Screener
NeoGenomics NEO Reportable Segment — Operating Income (Loss)
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by NeoGenomics in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The source filing: NeoGenomics’s 10-Q, filed July 28, 2026.
- Filed
- Jul 28, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001077183-26-000059
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Other research and development(1) | 9,934 | 7,859 | 18,393 | 16,961 |
| Other sales and marketing(1) | 26,666 | 23,217 | 50,142 | 44,927 |
| Impairment charges | — | 20,041 | — | 20,041 |
| Loss from operations | (9,771) | (47,628) | (28,012) | (75,453) |
| Interest income | 1,214 | 2,263 | 2,487 | 5,984 |
| Interest expense | (781) | (933) | (1,379) | (2,551) |
| Other (expense) income | (17) | 482 | (29) | 547 |
| Gain on extinguishment of debt (Note 6) | 11,181 | — | 11,181 | — |
Item 1. Financial Statements (unaudited)
FAQ
- What is NeoGenomics's reportable segment — operating income (loss)?
- NeoGenomics (NEO) reported reportable segment — operating income (loss) of -$9.77M in Q2 2026.
- How has NeoGenomics's reportable segment — operating income (loss) changed year-over-year?
- NeoGenomics's reportable segment — operating income (loss) increased by 79.5% year-over-year, from -$47.63M to -$9.77M.
- What is the long-term trend for NeoGenomics's reportable segment — operating income (loss)?
- Over 3 years (2022 to 2025), NeoGenomics's reportable segment — operating income (loss) has grown at a -9.7% compound annual growth rate (CAGR), from -$157.62M to -$115.88M.
- What does reportable segment — operating income (loss) mean?
- The profit or loss generated by the segment after subtracting all operating expenses from net revenue. It is the fundamental measure of the segment's core operational profitability and financial viability.
Ask your AI about NeoGenomics's reportable segment — operating income (loss).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude